The contract's strategic value may matter more than its revenue contribution
Optima Health PLC's (AIM:OPT, OTC:OHLTF, FRA:J3N) partnership with Perkbox, reported earlier today, adds modest incremental revenue to a business that is already growing rapidly, but the more interesting question is what it signals about the company's distribution ambitions.
The £6.5 million annual contract sits within the £8.3 million new business pipeline Optima disclosed at its December half-year results.
What it does do is hand Optima a direct line into Perkbox's corporate client base, a constituency it would otherwise have had to reach through its own sales effort.
That matters because Optima's growth story increasingly depends on winning large-scale contracts across both public and private sectors, as the £290 million Armed Forces deal and the pending acquisition of People Asset Management (PAM) illustrate.
Adding an established employee benefits platform as a distribution partner accelerates that reach without proportionate cost.
The valuation context is also worth noting: at 185p, Optima trades at roughly 6.8 times forecast FY27 EV/EBITDA, against acquisition multiples in the sector of 12 to 15 times.
That discount has persisted despite a string of contract wins and what Cavendish, the AIM broker, describes as a profitable, cash-generative business with meaningful capacity for further acquisitions.
Whether today's deal shifts that discount is unlikely in isolation, but it reinforces the direction of travel for a company building scale methodically.